With health care workers reporting increased rates of depression, anxiety, and stress during the COVID-19 pandemic, the study authors investigated posttraumatic stress symptoms in these frontline workers.
Several clinical practice guidelines on the treatment of schizophrenia have recently been updated in the United States. In order to understand the recommendations of current clinical practice guidelines, the study authors conducted a systematic literature review.
Study researchers examined the prevalence of major depressive disorder (MDD) during COVID-19 among US residents with and without a history of depressive disorders and the associations of current MDD with changes in negative and positive health behaviors.
The aims of this study were to model suicide trajectory groups across length of stay among inpatients at a psychiatric hospital and to determine whether emotional regulation problems and sleep issues differ between groups.
With atypical antipsychotics (AAPs) being prescribed off-label for treating dementia-related psychosis, the study authors evaluated the comparative efficacy, safety, and effectiveness of AAPS by conducting a network meta-analysis.
The study authors aimed to assess the real-world effectiveness of fremanezumab in patients with migraine and major depressive disorder or generalized anxiety disorder.
The initial aim of the Compassionate Home, Action Together (CHATogether) group was to use theater vignettes to promote emotional wellness in Asian American families.
The researchers’ goal was to assess eating disorder symptomatology in transgender populations as a function of gender affirmation (ie, hormone treatment or surgery) and health determinants (eg, anxiety, depression, and weight).
In this study, patients were assessed for hospital stay on the basis of treatment regimen.
The objective of this systematic review was to evaluate the efficacy of cognitive behavioral therapy and adaptations in managing mood and insomnia in people with dementia.
